@luxury the usual path is a JV with a Big Pharma to fastrack drug to market with the FDA.
eg. Merck and Molnupravir with Ridgeback Biotherapeutics,.
This is the normal path.
biT225 is looking like the low hanging fruit now.
Maybe Merck wants another pill type drug....if it wants a monopoly on the small molecule drugs?
This is the path Biotron is on.
Should get the CDC to fully sponsor and pay for the trial also.
$10 Billion Deal, page-8764
-
- There are more pages in this discussion • 4,561 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |